Skip to main content

Table 3 Treatment-related toxicity

From: Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study

Treatment-related toxicity

Grade 0-1

Grade 2

Grade 3

Grade 4

Grade 5

Acute toxicity

     

Lung

67 (98.5%)

1 (1.5%)

0

0

0

Esophagus

29 (42.7%)

21 (30.9%)

18 (26.4%)

0

0

Skin

67 (98.5%)

0

1 (1.5%)

0

0

Hematologic

     

  Hemoglobin

60 (88.2%)

3 (4.4%)

4 (5.9%)

1 (1.5%)

0

  Leucopenia

20 (29.4%)

26 (38.2%)

20 (29.4%)

2 (2.9%)

0

  Neutropenia

53 (77.9%)

3 (4.4%)

12 (17.7%)

0

0

  Thrombocytopenia

48 (70.6%)

13 (19.1%)

5 (7.4%)

2 (2.9%)

0

Gastrointestinal

57 (83.8%)

9 (13.2%)

2 (2.9%)

0

0

Late toxicity

     

Lung

64 (94.1%)

3 (4.4%)

1 (1.5%)

0

0

Esophagus

61 (89.7%)

4 (5.9%)

1 (1.5%)

0

2 (2.9%)

Heart

66 (97.1%)

2 (2.9%)

0

0

0